ADMA 8-K 2026-01-12

ADMA BIOLOGICS, INC. (ADMA) 8-K dated 2026-01-12 — accession 0001140361-26-000906. This URL is the filing, not the ADMA hub.

ADMA BIOLOGICS, INC. (ADMA) is a biotechnology company listed on US.

ADMA BIOLOGICS, INC. filed a 8-K on 2026-01-12. Accession 0001140361-26-000906.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ADMA revenue for 2025-12-31 was $510.2M. Net income was $146.9M. Revenue was up 19.6% from 2024-12-31 to 2025-12-31. ADMA currently screens at market cap $4.39B.

Not investment advice. The ADMA SEC hub lists recent forms. The stock page is the research view.